QTI Form 4: John C. Klock Jr. Receives 25k Options Vesting Through Aug 15, 2028
Rhea-AI Filing Summary
QT Imaging Holdings reported an insider grant of 25,000 stock options to John C. Klock Jr., a director and 10% owner. The options were granted on 08/11/2025 with an exercise price of $1.90 and cover 25,000 underlying shares of common stock. The filing indicates the options are held directly and shows an expiration date of 08/11/2035.
The grant vests over time: one-third vests on August 15, 2026, and the remaining two-thirds vest in eight equal quarterly installments each Nov 15, Feb 15, May 15, and Aug 15, becoming fully vested on August 15, 2028, subject to continued service. The Form 4 was signed by Mr. Klock on 08/13/2025.
Positive
- 25,000 stock options granted to a director and 10% owner, indicating insider alignment with shareholder value
- Time‑based vesting schedule (one‑third on 08/15/2026; fully vested on 08/15/2028) ties benefits to continued service
Negative
- None.
Insights
TL;DR: A director and 10% owner received a time‑vesting option grant, aligning long‑term incentives but not immediately dilutive.
The Form 4 documents a 25,000 stock option grant to John C. Klock Jr. on 08/11/2025 at a $1.90 exercise price, expiring 08/11/2035. The vesting schedule—one‑third on 08/15/2026 and the remainder in eight quarterly installments through 08/15/2028—ties full benefit to continued service, which is standard for retention and alignment. As the reporting person is both a director and a 10% owner, the grant increases insider equity stake and signals internal alignment with shareholder outcomes, though no absolute materiality assessment can be made from the filing alone.
TL;DR: The award is a conventional time‑based option grant with a ten‑year term and multi‑year vesting, consistent with retention-focused compensation.
The disclosed derivative is a stock option contract for 25,000 shares with an exercise price of $1.90 and a stated expiration of 08/11/2035. Vesting provisions described in the explanation create a staged incentive through mid‑2028. From a compensation design perspective, this structure encourages continued service and aligns pay with potential future share price appreciation; the Form 4 does not provide company‑level context (outstanding shares or percent dilution), so materiality cannot be judged solely from this filing.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 25,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. One-third of the grant will vest on August 15, 2026, and the remaining two-thirds will vest in eight equal quarterly installments on each subsequent November 15, February 15, May 15, and August 15, such that the grant will be fully vested on August 15, 2028, subject to continued service with the Issuer through each vesting date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
